Search Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupOther Solid Tumors (ped.)DiseaseNasopharyngeal CarcinomaSubgroupICD10C11.-C11.8C11.9MeSHNasopharyngeal CarcinomaSequencePAED CISP100/FU1000, Nasopharyngeal Ca, A (PID723) -|- B (PID682) -|- C (PID738)PAED CRBP500/FU1000, Nasopharyngeal Ca, A (PID681) -|- B (PID682) -|- C (PID738)ChemotherapyChemo-substanceInterferon beta-1aChemo-substanceInterferon beta-1aChemo-substanceInterferon beta-1aChemo-substanceInterferon beta-1aNo. Substances1 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationFirst lineTherapy phaseMaintenanceTherapy intentioncurativeRisksHypothyroidismIncrease AminotransferasesLeukopeniaOtotoxicity only studiesPublicationAuthorBuehrlen MDiseaseNasopharynxkarzinom, Stadium I- IV, unter 25 JahreOriginDepartment of Pediatric and Adolescent Medicine, University Hospital Aachen, Germany, NPC-2003-GPOH/DCOGProtocols in Revision 1 protocol foundProtocols under revision.PAED Interferon beta 1A 0.1m, Nasopharyngeal Carcinoma, Part C (PID738 V1.0)
